Favia G, Lumachi F, Gregianin M, Polistina F, Borsato S, D'Amico D F
Istituto di Clinica Chirurgica Generale I Università degli Studi di Padova.
Ann Ital Chir. 1997 Jul-Aug;68(4):517-22.
The incidence of unsuspected adrenal masses (incidentalomas) based on CT-scan results to be higher than in the past. The aim for our study was to establish some guidelines for an appropriate management.
From 1986 to 1995, 61 patients with no history or clinical findings suggestive of adrenal mass or adrenal hyperfunction were discovered by radiologic examination to have an incidentaloma larger than 1 cm. In each patient basal biochemical evaluations were obtained to exclude the presence of adrenal cortical or medullary dysfunction. There were 28 men and 33 (54.1%) women, with a mean age of 53 years (range 16-74). 19 patients underwent CT-guided fine-needle biopsy to exclude metastatic tumors. Furthermore in 29 patients 75-Se-selenomethyl-norcholesterol was performed and 17 were studied by MRI.
At CT-scan mean lesion diameter was 5.48 +/- 3.76 cm (range 2-23); 32 adrenal masses were right sided and 3 (4.9%) were bilateral. 17 patients had concordant scintigraphic imaging pattern, 6 bilateral uptake and 6 had discordant imaging. CT-guided FNAB showed malignancy in 9. Adrenalectomy was performed in 45 patients according to a score calculated by 4 parameters: age of the patients, size of the mass, scintigraphic pattern, MR imaging. Twenty-four had a score greater than 9 and in the remaining 21 patients in spite of a score lower than 10 adrenalectomy was performed based on: 1) increased size at CT scan follow-up (15 pts); 2) either suspected primitive malignant neoplasm at CT-guided FNAB or history of malignancy (6 pts); 3) elevated 24-hour dopamine (4 pts). In 12 (26.7%) patients a malignant tumor was found. There were not any statistically significant differences (p > 0.05) between the age of the patients with malignant neoplasms and those with benign masses, and between the size of the masses, which were 7.58 +/- 5.93 cm (range 2-23) and 5.03 +/- 2.81 cm (range 3-17) respectively. The difference in scores between the patients with malignant masses (12.17 +/- 2.95) and those with benign ones (9.09 +/- 1.33) was statistically significant (p < 0.01).
Since adrenal incidentaloma have a malignancy rate higher than the other adrenal tumors, it is crucial to outlinesome criteria to sort out the patients at risk for whom adrenalectomy is to be warranted. Based on our results we believe that patients with a score > 9 should undergo adrenalectomy.
基于CT扫描结果,未被怀疑的肾上腺肿块(偶发瘤)的发生率高于过去。我们研究的目的是制定一些适当管理的指导原则。
1986年至1995年,61例无肾上腺肿块或肾上腺功能亢进病史及临床症状的患者经放射学检查发现有直径大于1cm的偶发瘤。对每位患者进行基础生化评估以排除肾上腺皮质或髓质功能障碍。其中男性28例,女性33例(占54.1%),平均年龄53岁(范围16 - 74岁)。19例患者接受CT引导下细针穿刺活检以排除转移性肿瘤。此外,29例患者进行了75 - 硒 - 硒甲基去甲胆固醇检查,17例患者进行了MRI检查。
CT扫描显示平均病变直径为5.48±3.76cm(范围2 - 23cm);32个肾上腺肿块位于右侧,3个(4.9%)为双侧性。17例患者的闪烁显像模式一致,6例双侧摄取,6例显像不一致。CT引导下细针穿刺活检显示9例为恶性。根据患者年龄、肿块大小、闪烁显像模式、MRI成像4个参数计算的评分,45例患者接受了肾上腺切除术。24例患者评分大于9分,其余21例患者尽管评分低于10分,但基于以下情况进行了肾上腺切除术:1)CT扫描随访中肿块增大(15例);2)CT引导下细针穿刺活检怀疑为原发性恶性肿瘤或有恶性肿瘤病史(6例);3)24小时多巴胺升高(4例)。12例(26.7%)患者发现为恶性肿瘤。恶性肿瘤患者与良性肿块患者的年龄之间以及肿块大小之间(分别为7.58±5.93cm,范围2 - 23cm和5.03±2.81cm,范围3 - 17cm)无统计学显著差异(p>0.05)。恶性肿块患者与良性肿块患者的评分差异有统计学意义(p<0.01),分别为12.17±2.95和9.09±1.33。
由于肾上腺偶发瘤的恶性率高于其他肾上腺肿瘤,因此制定一些标准以筛选出有必要进行肾上腺切除术的高危患者至关重要。根据我们的结果,我们认为评分>9分的患者应接受肾上腺切除术。